Friday 6 November 2026 Export AQST’s income statement to Excel — free account

Aquestive Therapeutics, Inc.

AQST Healthcare Drug Manufacturers Specialty & Generic

Aquestive Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.5 million, down 22.6% from fiscal 2024.

Revenue: −41.0%
EPS: +6.14%
Free cash flow: +40.8%
Total debt: +69.5%

Quarter to September 2026, against a year earlier

3.58 0.08 −2.19%

Follow AQST

Alert me

Market cap: $460.0M
P/E: 0.0×
Fwd P/E: −7.7×
Dividend yield: —
F-score: 2/9
Altman Z: −2.19
Beneish M: −1.91
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	2	2	4	4
ROE Full definition →		178.61%	145.10%	121.12%	211.59%
ROA Full definition →		(63.99%)	(56.63%)	(69.29%)	(56.05%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(79.38%)	(67.38%)	(73.82%)	(85.35%)
Average Days of Receivables Full definition →		145.55	49.86	62.94	39.27
Free Cash Flow per Share Full definition →		(0.50)	(0.36)	(0.37)	(0.32)
Free Cash Flow Full definition →		(52.99)	(44.32)	(45.95)	(40.69)
Capital Expenditures Full definition →		(0.56)	(0.48)	(0.58)	(0.93)
Other line items
Cash ROIC Full definition →		(46.07%)	(43.54%)	(49.64%)	(57.90%)
Accounts Receivable Turnover Full definition →		3.55	5.81	5.11	5.73
Accounts Payable Turnover Full definition →		0.92	1.52	1.70	1.72
Inventory Turnover Full definition →		3.04	2.41	2.30	2.23
Average Days of Payables Full definition →		587.42	236.20	183.54	190.13
Days of Inventory on Hand Full definition →		121.35	160.25	150.81	157.60
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		38.59%	31.90%	29.38%	31.97%
Selling, General and Administrative Expense of Revenue Full definition →		179.25%	142.73%	135.17%	147.49%
Share Based Compensation of Revenue Full definition →		17.12%	16.62%	17.32%	17.85%
Interest Coverage Full definition →		(4.15)	(3.34)	(3.23)	(3.73)
Operating CF/Net income Full definition →		0.63	0.64	0.58	0.50
Depreciation/Fixed assets Full definition →		2.97	2.88	2.54	1.99
Capex/Depreciation Full definition →		(0.05)	(0.04)	(0.06)	(0.11)
Revenue per Share Full definition →		0.42	0.41	0.43	0.39
Operating CF per Share Full definition →		(0.49)	(0.36)	(0.36)	(0.32)
Capex per Share Full definition →		(0.01)	0.00	0.00	(0.01)
Capex to Sales Full definition →		0.01	0.01	0.01	0.02

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly